Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1989
Intraperitoneal penetration of cefpiromeJ Kavi, J P Ashby, R Wise, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 25, 2000
Phase relationships between cortical and muscle oscillations in cortical myoclonus: electrocorticographic assessment in a single caseJ F Marsden, P Ashby, J C Rothwell, et al.
The Journal of Antimicrobial Chemotherapy|March 3, 1999
The in-vitro activity of linezolid (U-100766) and tentative breakpointsR Wise, J M Andrews, F J Boswell, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsR Wise, J M Andrews, J P Ashby, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 11, 1999
On the focal nature of inhibition and facilitation in the human motor cortexP Ashby, C Reynolds, R Wennberg, et al.
The Biochemical Journal|December 15, 1978
Post-translational regulation of lipoprotein lipase activity in adipose tissueP Ashby, D P Bennett, I M Spencer, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteriaJ M Andrews, J P Ashby, G M Jevons, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1985
Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulationJ N Fox, B M Frier, M Armitage, et al.
The Biochemical Journal|December 1, 1970
The reverible dissociation and activity ofribosoma subunits of liver and skeletal muscle from ratsA von der Decke, P Ashby, D McIlreavy, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1991
The in-vitro and disc susceptibility testing of clarithromycin and its 14-hydroxy metaboliteM N Logan, J P Ashby, J M Andrews, et al.
Pageof 20